复发性脓毒症再入院的相关危险因素及其对1年死亡率的影响:法国全国性研究
基于法国2018年1月1日至2018年12月31日全国医保行政数据,纳入178017例15岁以上、首次脓毒症住院后存活出院的患者,分析出院后1年结局。患者出院后1年内22.3%死亡,73.8%至少再入院1次,再入院中18.1%与复发性脓毒症相关。56至75岁、合并癌症或肾脏疾病、首次住院时间长、纵隔或心脏感染者复发性脓毒症风险最高。复发性脓毒症再入院者1年死亡率更高(aOR 2.93;99%CI 2.78-3.09),合并癌症(aOR 4.35;99%CI 4.19-4.52)和痴呆(aOR 2.02;99%CI 1.90-2.15)者1年死亡风险最高。作者认为复发性脓毒症及其他可改变或不可改变的危险因素应纳入考量以改善患者诊疗路径和生存。
要点
- 178017例脓毒症存活出院患者中,出院后1年内22.3%死亡,73.8%至少再入院1次,再入院者中18.1%与复发性脓毒症相关。
- 复发性脓毒症再入院与1年死亡率升高相关(aOR 2.93;99%CI 2.78-3.09)。
- 合并癌症(aOR 4.35;99%CI 4.19-4.52)和痴呆(aOR 2.02;99%CI 1.90-2.15)的患者1年死亡风险最高。
- 56至75岁、合并癌症或肾脏疾病、首次住院时间长、纵隔或心脏感染者复发性脓毒症风险最高。
- 作者认为复发性脓毒症及其他可改变或不可改变的危险因素应纳入考量,以改善患者诊疗路径和生存。
适用人群与场景
- 法国本土2018年1月1日至2018年12月31日期间因首次脓毒症住院、年龄大于15岁且首次住院后存活出院的患者。
研究设计与关键结果
- 研究类型为基于法国全国医保行政数据的危险因素分析,纳入178017例首次脓毒症后存活出院患者。
- 出院后1年内22.3%死亡,73.8%至少再入院1次,再入院中18.1%与复发性脓毒症相关。
- 复发性脓毒症再入院患者1年死亡率更高(aOR 2.93;99%CI 2.78-3.09)。
- 合并症中,癌症(aOR 4.35;99%CI 4.19-4.52)和痴呆(aOR 2.02;99%CI 1.90-2.15)患者1年死亡风险最高。
- 56至75岁、合并癌症或肾脏疾病、首次住院时间长、纵隔或心脏感染者复发性脓毒症风险最高。
证据类型、等级与局限
- 证据类型:基于全国医保行政数据的危险因素分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,复发性脓毒症及其他已识别的可改变或不可改变危险因素应纳入考量,以改善患者诊疗路径和生存。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis is a complex health condition, leading to long-term morbidity and mortality. Understanding the risk factors for recurrent sepsis, as well as its impact on mid- and long-term mortality among other risk factors, is essential to improve patient survival.
METHODS: A risk factor analysis, based on French nationwide medico-administrative data, was conducted on a cohort of patients above 15 years old, hospitalized with an incident sepsis in metropolitan France between 1st January 2018 and 31st December 2018 and who survived their index hospitalization. Two main analyses, focusing on outcomes occurring 1-year post-discharge, were conducted: a first one to assess risk factors for recurrent sepsis and a second to assess risk factors for mortality.
RESULTS: Of the 178017 patients surviving an incident sepsis episode in 2018 and included in this study, 22.3% died during the 1-year period from discharge and 73.8% had at least one hospital readmission in acute care, among which 18.1% were associated with recurrent sepsis. Patients aged between 56 and 75, patients with cancer and renal disease, with a long index hospital stay or with mediastinal or cardiac infection had the highest odds of recurrent sepsis. One-year mortality was higher for patients with hospital readmission for recurrent sepsis (aOR 2.93; 99% CI 2.78-3.09). Among all comorbidities, patients with cancer (aOR 4.35; 99% CI 4.19-4.52) and dementia (aOR 2.02; 99% CI 1.90-2.15) had the highest odds of 1-year mortality.
CONCLUSION: Hospital readmission for recurrent sepsis is one of the most important risk factors for 1-year mortality of septic patients, along with age and comorbidities. Our study suggests that recurrent sepsis, as well as modifiable or non-modifiable other risk factors identified, should be considered in order to improve patient care pathway and survival.
参考来源
- Pandolfi F, Brun-Buisson C, Guillemot D, et al. One-year hospital readmission for recurrent sepsis: associated risk factors and impact on 1-year mortality-a French nationwide study. Crit Care. 2022. PMID: 36447252. doi:10.1186/s13054-022-04212-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。